Salivary alpha-synuclein as a potential diagnostic marker of Parkinson's disease

被引：0
|
作者：
Hrabos, D. [1 ]
Kaiserova, M. [2 ]
Kavalkova, M. [1 ]
Levkova, M. [1 ]
Mensikova, K. [2 ]
机构：
[1] Univ Hosp Olomouc, Dept Clin & Mol Pathol, Olomouc, Czech Republic
[2] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
来源：
BRAIN PATHOLOGY | 2023年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
eP-ND-A201
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: A systematic review and meta-analysis
    Kharel, Sanjeev
    Ojha, Rajeev
    Bist, Anil
    Joshi, Surya Prakash
    Rauniyar, Robin
    Yadav, Jayant Kumar
    AGING MEDICINE, 2022, 5 (01) : 53 - 62
  • [42] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
    Majbour, Nour K.
    Vaikath, Nishant N.
    van Dijk, Karin D.
    Ardah, Mustafa T.
    Varghese, Shiji
    Vesterager, Louise B.
    Montezinho, Liliana P.
    Poole, Stephen
    Safieh-Garabedian, Bared
    Tokuda, Takahiko
    Teunissen, Charlotte E.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    El-Agnaf, Omar M. A.
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [43] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Nour K. Majbour
    Nishant N. Vaikath
    Karin D. van Dijk
    Mustafa T. Ardah
    Shiji Varghese
    Louise B. Vesterager
    Liliana P. Montezinho
    Stephen Poole
    Bared Safieh-Garabedian
    Takahiko Tokuda
    Charlotte E. Teunissen
    Henk W. Berendse
    Wilma D. J. van de Berg
    Omar M. A. El-Agnaf
    Molecular Neurodegeneration, 11
  • [44] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
  • [45] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [46] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [47] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [48] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [49] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    NATURE, 1997, 388 (6639) : 232 - 233
  • [50] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
12345